• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP

LTR PHARMA LIMITED - Corporate Spotlight

24.7% ! 58.0¢
Market Cap $64.93M  !
Healthcare Biotechnology
Add to My Watchlist

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
58.0¢ 		Change
0.115(24.7%) 		Mkt cap ! $64.93M
Open High Low Value Volume
47.5¢ 58.0¢ 47.5¢ $1.630M 3.029M

Buyers (Bids)

No. Vol. Price($)
1 27566 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
58.5¢ 35000 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
LTP (ASX) Chart

Top Stories

HotCopper Highlights Week 37: LKY nextdoor to MP Materials; Service Stream's DoD win & more

Good Afternoon and welcome to HotCopper Highlights for Week 37, I’m Jon Davidson. In this segment the stocks you were watching and discussing the most this week on Australia’s #1 finance website, let’s get into it starting with the most viewed.Servi...
Week 37 Wrap: Markets often possess a poetic irony; warfare has brought back the 'circular economy' Welcome to HotCopper’s weekly wrap for Week 37 where it’s been another broadly dry week for the ASX200 as opposed to Wall Street, which appears to be tracking along per usual. That of course might not be too surprising given the stock market tends to retreat a litt...
EVR opens strong with funding, acquisition, and sales agreement announcements EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
WiseTech, COG, Neuren: All the biggest ASX director trades from the last week Welcome to HotCopper’s Director Trades column, where we take a look at all the most interesting director transactions from September 4-10.
The billion-dollar secret that could erase America's debt What if I told you there’s a dirty little secret sitting on America’s balance sheet? One that could turn the global financial system upside.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.